ENTX Entera Bio Ltd
Price (delayed)
$1.68
Market cap
$76.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.25
Enterprise value
$67.92M
Entera is a leader in the development of orally delivered large molecule therapeutics for use in areas with significant unmet medical need where adoption of injectable therapies is limited due
Highlights
Entera Bio's revenue has soared by 83% from the previous quarter
The debt has declined by 30% year-on-year and by 12% since the previous quarter
ENTX's quick ratio is down by 26% year-on-year but it is up by 19% since the previous quarter
The equity has increased by 25% since the previous quarter but it has declined by 22% year-on-year
ENTX's gross margin is down by 45% since the previous quarter
The net income is down by 7% year-on-year and by 4% since the previous quarter
Key stats
What are the main financial stats of ENTX
Market
Valuations
Earnings
Shares outstanding
45.42M
Market cap
$76.31M
Enterprise value
$67.92M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.66
Price to sales (P/S)
349.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
375.24
Revenue
$181,000
Gross profit
$9,000
Operating income
-$9.59M
Net income
-$9.54M
EBIT
-$9.53M
EBITDA
-$9.48M
Free cash flow
-$6.82M
Per share
Balance sheet
Liquidity
EPS
-$0.25
EPS diluted
-$0.25
Free cash flow per share
-$0.18
Book value per share
$0.22
Revenue per share
$0
TBVPS
$0.25
Total assets
$9.39M
Total liabilities
$1.31M
Debt
$272,000
Equity
$8.08M
Working capital
$7.8M
Debt to equity
0.03
Current ratio
7.63
Quick ratio
7.47
Net debt/EBITDA
0.88
Margins
Efficiency
Dividend
EBITDA margin
-5,238.1%
Gross margin
5%
Net margin
-5,271.3%
Operating margin
-5,295.6%
Return on assets
-102%
Return on equity
-119.5%
Return on invested capital
-21,776%
Return on capital employed
-116%
Return on sales
-5,263.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENTX stock price
How has the Entera Bio stock price performed over time
Intraday
3.07%
1 week
-7.44%
1 month
-9.19%
1 year
-9.68%
YTD
-20.75%
QTD
-1.18%
Financial performance
How have Entera Bio's revenue and profit performed over time
Revenue
$181,000
Gross profit
$9,000
Operating income
-$9.59M
Net income
-$9.54M
Gross margin
5%
Net margin
-5,271.3%
Entera Bio's revenue has soared by 83% from the previous quarter
ENTX's gross margin is down by 45% since the previous quarter
The net margin has increased by 43% since the previous quarter
ENTX's operating margin is up by 43% since the previous quarter
Growth
What is Entera Bio's growth rate over time
Valuation
What is Entera Bio stock price valuation
P/E
N/A
P/B
7.66
P/S
349.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
375.24
The EPS is up by 19% year-on-year and by 3.8% since the previous quarter
ENTX's P/B is 52% above its 5-year quarterly average of 4.9 but 15% below its last 4 quarters average of 8.7
The equity has increased by 25% since the previous quarter but it has declined by 22% year-on-year
Entera Bio's revenue has soared by 83% from the previous quarter
The stock's price to sales (P/S) is 18% less than its 5-year quarterly average of 415.3
Efficiency
How efficient is Entera Bio business performance
ENTX's ROIC has dropped by 134% since the previous quarter
The return on sales is up by 43% since the previous quarter
Entera Bio's ROA has decreased by 22% YoY and by 11% from the previous quarter
ENTX's return on equity is down by 17% year-on-year and by 11% since the previous quarter
Dividends
What is ENTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENTX.
Financial health
How did Entera Bio financials performed over time
ENTX's quick ratio is down by 26% year-on-year but it is up by 19% since the previous quarter
The current ratio has declined by 26% year-on-year but it is up by 15% since the previous quarter
The debt is 97% smaller than the equity
Entera Bio's debt to equity has decreased by 40% from the previous quarter and by 25% YoY
The debt has declined by 30% year-on-year and by 12% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.